The clinical biology of hormone-responsive breast cancer
- 31 March 1988
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 15 (1) , 33-51
- https://doi.org/10.1016/0305-7372(88)90008-4
Abstract
No abstract availableThis publication has 91 references indexed in Scilit:
- Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogensBiochemical and Biophysical Research Communications, 1987
- Is your initiator really necessary?Journal of Theoretical Biology, 1986
- The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic proteaseBiochemical and Biophysical Research Communications, 1986
- Mitoxantrone affects topoisomerase activities in human breast cancer cellsBiochemical and Biophysical Research Communications, 1986
- Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-ANature, 1986
- Topoisomerase-II activity in human leukemic and lymphoblastoid cellsBiochemical and Biophysical Research Communications, 1985
- Amplified expression of p21 ras protein in hormone-dependent mammary carcinomas of humans and rodentsBiochemical and Biophysical Research Communications, 1985
- Pitfalls in the dextran-coated charcoal assay of estrogen receptors in breast cancer tissueJournal of Steroid Biochemistry, 1985
- Hormone-regulated expression of cellular rasH oncogene in mammary carcinomas in ratsBiochemical and Biophysical Research Communications, 1984
- 579 Chemotherapy with estrogenic recruitment in advanced breast cancer. preliminary results of a phase II study of the E.O.R.T.C. breast cancer cooperative groupJournal of Steroid Biochemistry, 1983